Pfizer-BioNTech’s COVID-19 vaccine produces a much weaker immune response against the variant found in South Africa, a new study suggests

Press/Media: Expert Comment

PeriodFeb 18 2021

Media coverage

10

Media coverage

Keywords

  • COVID-19